Freeline Therapeutics Holdings plc Earnings Per Share, Basic and Diluted
Freeline Therapeutics Holdings plc reported Earnings Per Share, Basic and Diluted of -$0.63 per share for the 3-month period ending 2022-03-31, per its 6-K filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- Freeline Therapeutics Holdings plc earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.63.
- Freeline Therapeutics Holdings plc earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.98.
- Freeline Therapeutics Holdings plc earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$1.85.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.63 6-K · filed 2022-05-10 | |||
| 2021-12-31 | -$3.93 20-F · filed 2022-03-31 | |||
| 2021-09-30 | -$2.96 6-K · filed 2021-11-09 | |||
| 2021-06-30 | -$2.10 6-K · filed 2021-08-16 | |||
| 2021-03-31 | -$0.98 6-K · filed 2022-05-10 | |||
| 2020-12-31 | -$6.81 20-F · filed 2022-03-31 | |||
| 2020-09-30 | -$8.39 6-K · filed 2021-11-09 | |||
| 2020-06-30 | -$3.51 6-K · filed 2021-08-16 | |||
| 2020-03-31 | -$1.85 6-K · filed 2021-05-17 | |||
| 2019-12-31 | -$8.49 20-F · filed 2022-03-31 | |||
| 2019-06-30 | -$4.62 6-K · filed 2020-10-29 | |||
| 2018-12-31 | -$7.20 20-F · filed 2021-03-31 |